AristaMD is a digital health startup founded in 2013 and headquartered in the United States. The company's slogan, "Transforming Primary Care • Improving Patient Outcomes," encapsulates its mission to revolutionize the healthcare industry. AristaMD offers care transition solutions, such as eConsult, video consults, and referral management tools, aimed at empowering providers to enhance patient care through electronic physician-to-physician consultations and the facilitation of specialist visits. Their services also include automatic follow-up activities critical to patient care and peer-to-peer reviews for insurance authorization. In its latest funding round, AristaMD secured a significant $16.50M Series C investment on 14 November 2023, signaling investor confidence in the company's innovative approach to improving healthcare access and quality. While the specific investors of this round are not disclosed, the substantial investment reflects the growing interest in digital health and healthcare technology. AristaMD's focus on leveraging technology to streamline the patient referral process and ensure equitable access to high-quality care positions it as a compelling player in the ever-evolving healthcare landscape.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series C | $16.50M | - | 14 Nov 2023 | |
Series C | Unknown | 1 | 30 Mar 2022 | |
Series B | $6.00M | 2 | 14 Jul 2020 | |
Series B | $18.00M | 5 | The CU Healthcare Innovation Fund | 31 Mar 2020 |
Venture Round | $500.00K | - | 08 Jan 2017 |
No recent news or press coverage available for AristaMD.